Skip to content
Search

Latest Stories

After Robbie Turner, Gail Fleming leaves RPS

Gail Fleming, the director of Education and Professional Development at the Royal Pharmaceutical Society, has decided to resign. Thursday, April 7 will be her last day at the RPS.

In a statement, chief executive Paul Bennett said: “On the 4th March we announced that we were proposing some changes to our executive structure.


“Further to my update on the 24th of March I can announce that Gail Fleming has decided to leave her role as Director of Education and Professional Development and her last day with us will be 07 April 2022."

Bennett wished Fleming luck and thanked "her for her excellent work since joining the organisation in 2018".

He added: “I will be updating everyone on how any changes to our structure enable us to deliver our Royal Charter obligations and our five-year strategy.”

Robbie Turner Robbie Turner

Last week, RPS also announced that "Robbie Turner has decided to leave his role as director of Pharmacy and Membership Experience and his last day with us will be 31 March 2022."

Earlier, on a proposed change to the executive structure, RPS president Claire Anderson commented: “I deeply regret seeing so much speculation in the public domain about a proposed change to the Executive Team when no decision has yet been made, and feel for those involved.

“This is an organisational decision, as it is about operational matters. RPS finances are on a secure footing and this proposal is not about cost savings. We intend to continue our investment in education and professional leadership for the future of the pharmacy profession.

“Our excellent and dedicated teams will continue to advocate on behalf of the profession across all sectors and areas of practice, including education, workforce issues, independent prescribing and inclusion and diversity.

"In particular, our work on education, including post-registration curricula, assessment and credentialing, workforce planning, leadership development and mentoring are strategically important to our profession, right from undergraduate level through foundation to advanced and consultant practice.

"We are completely committed to maintaining this work and should the proposal go ahead, there would still be a leader on the Executive with responsibility for delivering on our education strategy."

In March, RPS said that it had identified two roles at potential risk of redundancy, but did not specify which two roles were going to be axed.

More For You

First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
Antibiotic prescribing for sore throats in England's pharmacies is twice as high as in Wales

Antibiotic supply rate was 72.7% under England’s Acute Sore Throat Pharmacy First compared to just 29.9% under Wales’ Sore Throat Test and Treat (STTT) scheme in six months.

Getty Images

Sore throat treatment: England pharmacies twice as likely to prescribe antibiotics as Welsh counterparts

A new study has highlighted significant differences in antibiotic use for sore throat treatment between pharmacies in England and Wales, suggesting that incorporating throat swabs to confirm bacterial infections could help reduce “unnecessary antibiotic supply.”

The study, published in the Journal of Antimicrobial Chemotherapy and first reported by The Independent, found that pharmacies in England were twice as likely to prescribe antibiotics for sore throats compared to those in Wales.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less